Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New bispecific antibodies for cancer prepared by Genmab

Nov. 21, 2012

Dicerna's Dicer Substrate siRNA in lipid nanoparticles targets beta-catenin

Nov. 21, 2012

Astellas files sNDA for Tarceva in specific NSCLC subtype

Nov. 21, 2012

Researchers at Bayer synthesize new cyclin-dependent kinase inhibitors

Nov. 21, 2012

Zytiga receives positive CHMP recommendation for castration-resistant prostate cancer

Nov. 20, 2012

Bayer patents new TTK inhibitors

Nov. 20, 2012

Researchers publish results of first-in-human trial of APR-246

Nov. 20, 2012

Novel pegylated camptothecin derivatives disclosed by Chinese researchers

Nov. 20, 2012

Nerviano Medical Sciences presents new JAK2 inhibitors

Nov. 19, 2012

Zaltrap receives positive CHMP opinion for metastatic colorectal cancer

Nov. 19, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...